Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

InMed Pharmaceuticals (INM) Asset Utilization Ratio (2022 - 2025)

InMed Pharmaceuticals has reported Asset Utilization Ratio over the past 4 years, most recently at 0.37 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 27.95% year-over-year to 0.37; the TTM value through Dec 2025 reached 0.37, down 27.95%, while the annual FY2025 figure was 0.36, 1.72% up from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.37 at InMed Pharmaceuticals, up from 0.33 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.55 in Q1 2025 and troughed at 0.1 in Q4 2022.
  • A 4-year average of 0.34 and a median of 0.37 in 2023 define the central range for Asset Utilization Ratio.
  • Biggest five-year swings in Asset Utilization Ratio: soared 308.98% in 2023 and later dropped 27.95% in 2025.
  • Year by year, Asset Utilization Ratio stood at 0.1 in 2022, then soared by 308.98% to 0.42 in 2023, then rose by 21.52% to 0.51 in 2024, then dropped by 27.95% to 0.37 in 2025.
  • Business Quant data shows Asset Utilization Ratio for INM at 0.37 in Q4 2025, 0.33 in Q3 2025, and 0.4 in Q2 2025.